Molecular characterization of newly diagnosed acute myeloid leukemia patients aged 60 years or older: a report from the Beat AML clinical trial

Affiliations

• ¹ Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.
• ² Department of Medicine, The Ohio State University, Columbus, OH, USA.
• ³ Division of Hematology/Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.
• ⁴ Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
• ⁵ Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, USA.
• ⁶ Servier Pharmaceuticals, LLC, Boston, MA, USA.
• ⁷ Department of Medicine, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.
• ⁸ Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA, USA.
• ⁹ Department of Medicine, University of Chicago, Chicago, IL, USA.
• ¹⁰ Department of Medicine, UPMC Hillman Cancer Center, Pittsburgh, PA, USA.
• ¹¹ Division of Hematology and Hematologic Malignancies, The University of Utah, Salt Lake City, UT, USA.
• ¹² Department of Internal Medicine, Versiti Blood Research Institute and Medical College of Wisconsin, Milwaukee, WI, USA.
• ¹³ Division of Hematology, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.
• ¹⁴ Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.
• ¹⁵ Department of Internal, Medicine Mayo Clinic, Jacksonville, FL, USA.
• ¹⁶ Department of Medicine, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA, USA.
• ¹⁷ Department of Internal Medicine, University of Cincinnati, Cincinnati, OH, USA.
• ¹⁸ Leukemia and Lymphoma Society, Rye Brook, NY, USA.
• ¹⁹ Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA. yazan.madanat@utsouthwestern.edu.